0000950170-24-008802.txt : 20240130 0000950170-24-008802.hdr.sgml : 20240130 20240130160109 ACCESSION NUMBER: 0000950170-24-008802 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240126 FILED AS OF DATE: 20240130 DATE AS OF CHANGE: 20240130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sukenick Scott CENTRAL INDEX KEY: 0001722886 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36365 FILM NUMBER: 24578101 MAIL ADDRESS: STREET 1: 101 HUDSON STREET, SUITE 3610 CITY: JERSEY CITY STATE: NJ ZIP: 07302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCYNEXIS INC CENTRAL INDEX KEY: 0001178253 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 562181648 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 BUSINESS PHONE: 201-884-5485 MAIL ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 4 1 ownership.xml 4 X0508 4 2024-01-26 0001178253 SCYNEXIS INC SCYX 0001722886 Sukenick Scott 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302 false true false false Chief Legal Officer false Common Stock 2024-01-26 4 A false 143675 0 A 351374 D Employee Stock Option (Right to Buy) 1.86 2024-01-26 4 A false 215515 0 A 2034-01-25 Common Stock 215515 215515 D Represents restricted stock units that vest one third per year over three years as measured from February 15, 2024. Includes 4,100 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in March 2023 (100 shares) and September 2023 (4,000 shares). 1/48th of the shares subject to the option vest monthly for 48 months as measured from February 15, 2024. /s/ Robert F. Joyce Jr., by Power of Attorney 2024-01-30